MARKET WIREReuters • 3h ago
Russia's FSB says minor detained over park attack threat after US tip-off - ReutersRussia's FSB says minor detained over park attack threat after US tip-off Reuters
Why NSPR Stock dropped -3.55% Today — RQD Quant Desk Flash
$0.45 -3.55% NASDAQ • Live Quote vs Prior Daily Close (Synced Snapshot)
EXT / AFTER-HRS: $0.45
InspireMD Inc. (NSPR) carries a Roarable Rating of D- (Sell) with 38/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.
ROARABLE D- • RED ALERT
Cap $21.0M
⚡ INSTANT AI QUANT PREVIEW • $0 FREE TIER
Click Any Pre-Computed AI Quant Specialist Briefing on NSPR Below — or Connect Your Own ChatGPT / Claude
🤖 Mara Quenwick • AI Quant Lead (Click for Instant Brief)
Is NSPR stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
▼
As of 2026-11-01, InspireMD Inc. (NASDAQ: NSPR) is rated D- (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 38/100 at a spot price of $0.45 (-3.55% 1D, market cap $21.0M). Pillar breakdown: Fundamental Cash Engine 6/20, Institutional 13F & Options Flow 11/20, Executive Insider Alignment 8/20, FRED Macro Regime Fit 8/20, and SEC Balance-Sheet Forensics 5/20. Across 1016 tracked Health Care issuers, NSPR ranks #727 in composite RQD confidence.
✓ Pre-computed one-to-many AI Quant brief
🤖 Ellis Vennor • AI Peer & Flow Quant (Click for Instant Brief)
How does NSPR compare to PLRZ and PMI in the Health Care sector?
▼
Within the Health Care sector (Medical/Dental Instruments), NSPR carries a Roarable D- (38/100 RQD), trailing P/E of N/A, gross margin of 29.5%, and ROIC of -35.0%. By comparison, PLRZ (Polyrizon Ltd.) holds a D- grade (42/100 RQD, P/E N/A, ROIC -25.1%, cap $21.9M) and PMI (Picard Medical Inc.) posts a C- grade (61/100 RQD, P/E N/A, ROIC —, cap $19.9M). Among the 5-stock peer group, NSPR leads on earnings multiple (N/A) while RVP leads on capital efficiency (-23.3% ROIC).
✓ Pre-computed one-to-many AI Quant brief
🤖 Gideon Ashmere • AI SEC 10-K Forensics (Click for Instant Brief)
What are the biggest fundamental strengths and SEC risk factors for NSPR?
▼
Per NSPR's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001433607), InspireMD Inc. generated $9.0M in revenue (+28.1% YoY), -$48.8M in net income, and -$36.8M in free cash flow against $69.4M in total assets and $0 in total debt. Key quantitative strengths: Established market leader in Health Care with deep daily trading liquidity.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.
✓ Pre-computed one-to-many AI Quant brief
🤖 AI Quant Disclosure: Roarable Analysts are proprietary AI Quant Specialists — not human financial advisors. Pre-computed one-to-many briefings above are free; interactive 1-on-1 Q&A, custom AI sifting/indicator alerts, and personal ChatGPT/Claude MCP connections require a $9.95/mo Pro account (currently waitlist-only).
INTERACTIVE SCENARIO DECK:
EXT / AFTER-HRS: $0.45 (-0.83%)🧬 Disciplined Float (+0.72% YoY Shares)⚙️ Cash Engine: 6/20 (E) • 0% FCF Margin
Verify 90D Bucket Audit →📊 Historical Track Record Warning: Scores below 50 (38/100 · D-) historically underperformed SPY in 71% of rolling 90-day windows (-7.8% avg 90D alpha vs SPY • 29.0% hit rate).
Audit Bucket Track Record →RQD QUANT TACHOMETERRED ALERT • D-
3-of-3 JEV AI Jury Bearish Warning
Cash
SEC
Whale
Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer
5-PILLAR SNOWFLAKE RADARRw D- · Rk D-
Each axis scored 0–20
12M PRICE TARGET CONE-8.9% Base Target
WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for NSPR)Realized 20D OHLCV Swing Band: ±12.5%
Deterministic 5-Pillar Attribution (38/100 Composite)
🔍 WHY NSPR SCORES 38/100 (D-) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag
▲ #1 Bullish Driver: Whale & Options Positioning+11/20 pts (29% of score)
20D Institutional Volume Accumulation (±12.5% realized swing band)
▲ #2 Bullish Driver: SEC 10-K Forensic Risk+8/20 pts (21% of score)
Altman Z-Score 3.80 (FORTRESS SAFE (>3.0)) • Piotroski F-Score 4/9
▼ #1 Drag / Risk Factor: Insider Conviction & Share Dilution5/20 pts (-15 pt drag)
Disciplined Float (+0.72% YoY Shares) & executive Form 4 sales trim 15 pts from alignment
📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current
Q1 (-3Q)Grade D$0.52-11.5% Next Q
46
Q2 (-2Q)Grade D$0.46-2.2% Next Q
43
Q3 (-1Q)Grade D$0.45+0% Next Q
41
CurrentGrade D-$0.45-7.8% Hist 90D α
38
Trajectory: D (46) → D- (38)Full Audit →
⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)CONTRARIAN TURNAROUND & SHORT-SQUEEZE DOSSIER
⚔️ Adversarial Opposing Case: What Could Spark a NSPR Turnaround Squeeze
While NSPR currently carries a cautious 38/100 (D-) rating due to Insider Conviction & Share Dilution (5/20), shorts face asymmetric squeeze risk if free cash flow inflects or management executes accretive buybacks.
🚀 Contrarian Squeeze Trigger #1
Established market leader in Health Care with deep daily trading liquidity.
🚀 Contrarian Squeeze Trigger #2
Options & Short-Covering Gamma: Reclaiming the 50-day SMA ($0.66) and Max Pain ($0.47) forces dealer call-delta covering toward $2.52.
🚀 Contrarian Squeeze Trigger #3
Forensic Repair Trigger: Halting share dilution (Disciplined Float (+0.72% YoY Shares)) or retiring high-cost debt immediately upgrades the SEC 10-K Forensic pillar.
🎲 LIVE PREDICTION MARKET ODDS TIED TO $NSPR• $2.4M Crowd Pool • Kalshi / Polymarket Composite
Contract: “NSPR Beats Next Quarter EPS Consensus (Dec 30, 2026) & Holds Above 200D SMA”
AUTOMATED RQD QUANT DESK MOVER BRIEFINGFull Market News Desk →
Why NSPR Stock dropped -3.55% Today — RQD Quant Desk Flash
InspireMD Inc. (NSPR) dropped -3.55% to $0.45, trading at 2% of its 52-week range ($0.43 – $2.4). Stretched risk/reward at current multiples (-35% return on capital) under elevated 10-year interest-rate pressure.
- ▸Technical Tape: Trading at 2% of its 52-week range ($0.43 – $2.4) with RSI-14 at 30.2 (OVERSOLD (<32)).
- ▸Volatility Profile: Historical 20-day realized swing band of ±12.5% around $0.45 (no active unusual options sweep snapshot on file).
- ▸Fundamental Anchor: Roarable D- (Sell) backed by 29.5% gross margin and $0 annual free cash flow.
Live NSPR Headlines & Catalysts
MARKET WIREReuters • 3h ago
Oil slips more than 1% as talks continue on ending Iran war - ReutersOil slips more than 1% as talks continue on ending Iran war Reuters
MARKET WIREReuters • 4h ago
Nine people dead in Learjet crash in south Florida, officials say - ReutersNine people dead in Learjet crash in south Florida, officials say Reuters
MARKET WIREReuters • 6h ago
Iran's IRGC Navy says two tankers 'exploded' after hitting mines in Hormuz - ReutersIran's IRGC Navy says two tankers 'exploded' after hitting mines in Hormuz Reuters
MARKET WIRECNBC • 8h ago
Here are 3 big things we're watching in the stock market in the week aheadThe market could use a few victories in the days ahead, which will be filled with more earnings, an election, and jobs data.
MARKET WIRECNBC • 8h ago
Democratic Rep. Stevens endorses Rogers over El-Sayed in Michigan Senate electionHaley Stevens had lost the Democratic nomination for Senate in Michigan to Abdul El-Sayed earlier this year.
RISK WATCHReuters • 10h ago
Israeli strikes kill eight people in Gaza - medics say - ReutersIsraeli strikes kill eight people in Gaza - medics say Reuters
MARKET WIREReuters • 11h ago
Iran, Qatari mediators hold third day of talks to end US-Iran war - ReutersIran, Qatari mediators hold third day of talks to end US-Iran war Reuters
ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk
Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring NSPR)
- ✓Walkthrough of NSPR's RQD Radar, SEC cash-conversion gap & downside invalidation levels
- ✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
- ✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks
RQD INSIDER CLUB WAITLIST$49/YR PLANNED
Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?
NSPR // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: -61.86%🛡️ HOLDING TREND SUPPORT
2026-10-30O $0.44H $0.47L $0.44C $0.45VOL 478.7K
RES: $0.80SUP: $0.42SMA50: $0.66SMA200: $1.07
PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK
NSPR Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure
Share Count & Dilution Monitor (#25)
Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).
Reverse-DCF Expectations Hurdle (#30)
8.0%/yr Implied 5Y Growth
vs. +28.1% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
Ellis Vennor Setup Ledger (#33)
No active Ellis Vennor swing setup published on NSPR today. View full Setup Ledger →
🦋 Documented & Second-Order Butterfly Connections
Open Graph →
No direct multi-tier Butterfly edges indexed yet for NSPR. Explore sector supply chains on /butterfly.
AI Analyst Theses, Washington Policy & Company Video
🎬 No recent verified company-specific video clip queued for NSPR today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →
DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK
📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (NSPR)
Health Care Rank #727 of 1016
⚔️ PLRZ vs NSPR Full Matrix →
1. Head-to-Head Health Care Peer Comparison (NSPR vs. PLRZ, PMI, RVP, MODD)
Industry: Medical/Dental Instruments (120 Tracked Issuers)Across 1016 tracked Health Care securities in the Roarable RQD universe, InspireMD Inc. (NSPR) ranks #727 by composite RQD confidence (38/100, grade D-) and #829 by equity capitalization ($21.0M). Within this direct 5-issuer industry benchmark cohort, NSPR leads on earnings valuation at N/A trailing P/E, while RVP leads on capital efficiency and profitability with -23.3% ROIC and 0.1% gross margin. PMI currently holds the highest overall quantitative score in the immediate peer group at 61/100 (C-) compared with NSPR at 38/100 (D-).
| Ticker / Company | Roarable Grade | RQD Score | Trailing P/E | Gross Margin | ROIC | 1D Change | Market Cap | Head-to-Head |
|---|---|---|---|---|---|---|---|---|
| NSPR
ACTIVE
InspireMD Inc. | D- | 38/100 | — | 29.5% | -35.0% | -3.55% | $21.0M | Benchmark Subject |
| PLRZ Polyrizon Ltd. | D- | 42/100 | — | — | -25.1% | +4.57% | $21.9M | /plrz-vs-nspr → |
| PMI Picard Medical Inc. | C- | 61/100 | — | — | — | +12.17% | $19.9M | /pmi-vs-nspr → |
| RVP Retractable Technologies Inc. | E | 33/100 | — | 0.1% | -23.3% | -1.15% | $17.3M | /rvp-vs-nspr → |
| MODD Modular Medical Inc. | D- | 36/100 | — | — | -35.0% | -9.95% | $16.3M | /modd-vs-nspr → |
2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)
SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0001433607In its most recent audited fiscal period (FY2025, filed 2025-12-31), InspireMD Inc. (NSPR) reported GAAP revenue of $9.0M (+28.1% vs. FY2024 revenue of $7.0M , and +44.7% cumulative change since FY2023) , GAAP net income of -$48.8M, operating cash flow of -$35.1M, and free cash flow of -$36.8M (-58.0% YoY). On the balance sheet, NSPR closed FY2025 with $69.4M in total assets against $0 in total debt (Altman Z-Score: N/A, Piotroski F-Score: 4/9).
| Fiscal Period | Filing Date | Revenue | Net Income | Operating Cash Flow | Free Cash Flow | Total Assets | Total Debt |
|---|---|---|---|---|---|---|---|
| FY2025 (FY) | 2025-12-31 | $9.0M | -$48.8M | -$35.1M | -$36.8M | $69.4M | — |
| FY2024 (FY) | 2024-12-31 | $7.0M | -$32.0M | -$21.9M | -$23.3M | $46.8M | — |
| FY2023 (FY) | 2023-12-31 | $6.2M | -$19.9M | -$16.4M | -$16.4M | — | — |
3. NSPR Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)
✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLEDIs NSPR stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
As of 2026-11-01, InspireMD Inc. (NASDAQ: NSPR) is rated D- (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 38/100 at a spot price of $0.45 (-3.55% 1D, market cap $21.0M). Pillar breakdown: Fundamental Cash Engine 6/20, Institutional 13F & Options Flow 11/20, Executive Insider Alignment 8/20, FRED Macro Regime Fit 8/20, and SEC Balance-Sheet Forensics 5/20. Across 1016 tracked Health Care issuers, NSPR ranks #727 in composite RQD confidence.
How does NSPR compare to PLRZ and PMI in the Health Care sector?
Within the Health Care sector (Medical/Dental Instruments), NSPR carries a Roarable D- (38/100 RQD), trailing P/E of N/A, gross margin of 29.5%, and ROIC of -35.0%. By comparison, PLRZ (Polyrizon Ltd.) holds a D- grade (42/100 RQD, P/E N/A, ROIC -25.1%, cap $21.9M) and PMI (Picard Medical Inc.) posts a C- grade (61/100 RQD, P/E N/A, ROIC —, cap $19.9M). Among the 5-stock peer group, NSPR leads on earnings multiple (N/A) while RVP leads on capital efficiency (-23.3% ROIC).
What are the biggest fundamental strengths and SEC risk factors for NSPR?
Per NSPR's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001433607), InspireMD Inc. generated $9.0M in revenue (+28.1% YoY), -$48.8M in net income, and -$36.8M in free cash flow against $69.4M in total assets and $0 in total debt. Key quantitative strengths: Established market leader in Health Care with deep daily trading liquidity.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.
Where is NSPR trading relative to its 50-day, 200-day, and 52-week technical levels?
NSPR last traded at $0.45 (-3.55% on volume of 207,120 shares), positioning the stock -31.82% below its 50-day simple moving average ($0.66) and -57.94% below its 200-day simple moving average ($1.07). Across its 52-week range of $0.43 to $2.40, NSPR sits at the 1.0% percentile with a 14-day RSI of 30.2 (OVERSOLD (<32)) and an implied next-earnings move of ±12.5% ($1.00 to $0.51).
NSPR Investor FAQ & Complete 8-Part Research Index
100% OPEN ACCESS • SEC EDGAR × CBOE × FREDWhy is NSPR stock moving today?
Why NSPR Stock dropped -3.55% Today — RQD Quant Desk Flash. Stretched risk/reward at current multiples (-35% return on capital) under elevated 10-year interest-rate pressure.